Literature DB >> 27352824

Mesenchymal Stromal Cells are Readily Recoverable from Lung Tissue, but not the Alveolar Space, in Healthy Humans.

K A Sinclair1,2, S T Yerkovich3,4, T Chen5, J L McQualter6, P M-A Hopkins3,4, C A Wells5, D C Chambers3,4.   

Abstract

Stromal support is critical for lung homeostasis and the maintenance of an effective epithelial barrier. Despite this, previous studies have found a positive association between the number of mesenchymal stromal cells (MSCs) isolated from the alveolar compartment and human lung diseases associated with epithelial dysfunction. We hypothesised that bronchoalveolar lavage derived MSCs (BAL-MSCs) are dysfunctional and distinct from resident lung tissue MSCs (LT-MSCs). In this study, we comprehensively interrogated the phenotype and transcriptome of human BAL-MSCs and LT-MSCs. We found that MSCs were rarely recoverable from the alveolar space in healthy humans, but could be readily isolated from lung transplant recipients by bronchoalveolar lavage. BAL-MSCs exhibited a CD90Hi , CD73Hi , CD45Neg , CD105Lo immunophenotype and were bipotent, lacking adipogenic potential. In contrast, MSCs were readily recoverable from healthy human lung tissue and were CD90Hi or Lo , CD73Hi , CD45Neg , CD105Int and had full tri-lineage potential. Transcriptional profiling of the two populations confirmed their status as bona fide MSCs and revealed a high degree of similarity between each other and the archetypal bone-marrow MSC. 105 genes were differentially expressed; 76 of which were increased in BAL-MSCs including genes involved in fibroblast activation, extracellular matrix deposition and tissue remodelling. Finally, we found the fibroblast markers collagen 1A1 and α-smooth muscle actin were increased in BAL-MSCs. Our data suggests that in healthy humans, lung MSCs reside within the tissue, but in disease can differentiate to acquire a profibrotic phenotype and migrate from their in-tissue niche into the alveolar space. Stem Cells 2016;34:2548-2558.
© 2016 AlphaMed Press.

Entities:  

Keywords:  Lung; Mesenchymal stem cells; Mesenchymal stromal cells; Microarray; Transcriptome

Mesh:

Substances:

Year:  2016        PMID: 27352824     DOI: 10.1002/stem.2419

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  15 in total

Review 1.  Lung-resident mesenchymal stromal cells are tissue-specific regulators of lung homeostasis.

Authors:  Stefanie Noel Sveiven; Tara M Nordgren
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-05-13       Impact factor: 5.464

2.  Endoplasmic reticulum stress modulates the fate of lung resident mesenchymal stem cell to myofibroblast via C/EBP homologous protein during pulmonary fibrosis.

Authors:  Xiaoyu Yang; Wei Sun; Xiaoyan Jing; Qian Zhang; Hui Huang; Zuojun Xu
Journal:  Stem Cell Res Ther       Date:  2022-06-28       Impact factor: 8.079

3.  Mesenchymal Stem Cell Therapy Protects Lungs from Radiation-Induced Endothelial Cell Loss by Restoring Superoxide Dismutase 1 Expression.

Authors:  Diana Klein; Jennifer Steens; Alina Wiesemann; Florian Schulz; Farnusch Kaschani; Katharina Röck; Masahiro Yamaguchi; Florian Wirsdörfer; Markus Kaiser; Jens W Fischer; Martin Stuschke; Verena Jendrossek
Journal:  Antioxid Redox Signal       Date:  2016-11-14       Impact factor: 8.401

4.  Characterization of intercellular communication and mitochondrial donation by mesenchymal stromal cells derived from the human lung.

Authors:  Kenneth Andrew Sinclair; Stephanie Terase Yerkovich; Peter Mark-Anthony Hopkins; Daniel Charles Chambers
Journal:  Stem Cell Res Ther       Date:  2016-07-12       Impact factor: 6.832

Review 5.  Autologous Cell Seeding in Tracheal Tissue Engineering.

Authors:  Elizabeth F Maughan; Robert E Hynds; Toby J Proctor; Sam M Janes; Martin Elliott; Martin A Birchall; Mark W Lowdell; Paolo De Coppi
Journal:  Curr Stem Cell Rep       Date:  2017-10-26

6.  Multipotent mesenchymal stem cells in lung fibrosis.

Authors:  Katrin E Hostettler; Amiq Gazdhar; Petra Khan; Spasenija Savic; Luca Tamo; Didier Lardinois; Michael Roth; Michael Tamm; Thomas Geiser
Journal:  PLoS One       Date:  2017-08-21       Impact factor: 3.240

Review 7.  Mesenchymal stem cells-derived extracellular vesicles in acute respiratory distress syndrome: a review of current literature and potential future treatment options.

Authors:  Trushil G Shah; Dan Predescu; Sanda Predescu
Journal:  Clin Transl Med       Date:  2019-09-12

Review 8.  Dissecting the Role of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis: Cause or Solution.

Authors:  Anna Valeria Samarelli; Roberto Tonelli; Irene Heijink; Aina Martin Medina; Alessandro Marchioni; Giulia Bruzzi; Ivana Castaniere; Dario Andrisani; Filippo Gozzi; Linda Manicardi; Antonio Moretti; Stefania Cerri; Riccardo Fantini; Luca Tabbì; Chiara Nani; Ilenia Mastrolia; Daniel J Weiss; Massimo Dominici; Enrico Clini
Journal:  Front Pharmacol       Date:  2021-07-05       Impact factor: 5.810

9.  Host Defense against Klebsiella pneumoniae Pneumonia Is Augmented by Lung-Derived Mesenchymal Stem Cells.

Authors:  Tirumalai Rangasamy; Laxman Ghimire; Liliang Jin; John Le; Sivakumar Periasamy; Sagar Paudel; Shanshan Cai; Samithamby Jeyaseelan
Journal:  J Immunol       Date:  2021-08-02       Impact factor: 5.426

10.  Alk5/Runx1 signaling mediated by extracellular vesicles promotes vascular repair in acute respiratory distress syndrome.

Authors:  Trushil Shah; Shanshan Qin; Mona Vashi; Dan N Predescu; Niranjan Jeganathan; Cristina Bardita; Balaji Ganesh; Salvatore diBartolo; Louis F Fogg; Robert A Balk; Sanda A Predescu
Journal:  Clin Transl Med       Date:  2018-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.